𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factors

✍ Scribed by Alexander J V Thompson; Anna Ayres; Lilly Yuen; Angeline Bartholomeusz; D Scott Bowden; David M Iser; Robert Y M Chen; Barbara Demediuk; Gideon Shaw; Sally J Bell; Katrina J R Watson; Stephen A Locarnini; Paul V Desmond

Book ID
108951102
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
181 KB
Volume
22
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical course and predictive factors o
Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients
✍ Mashu Aizawa; Akihito Tsubota; Kiyotaka Fujise; Keiko Tatsuzawa; Midori Kono; Sa πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

## Abstract The aims of this study were to assess the long‐term efficacy of lamivudine (LAM) plus adefovir dipivoxil (ADV) combination therapy in patients with chronic hepatitis B resistant to LAM, to identify predictive factors of complete viral response (HBV‐DNA <2.6 log copies/ml at 12 months of

Clinical outcome of HBeAg-negative chron
Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
✍ Dr. Vito Di Marco; Alfredo Marzano; Pietro Lampertico; Pietro Andreone; Teresa S πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 869 KB

The effect of lamivudine treatment on the outcome of patients with hepatitis B e antigen (HBeAg)-negative chronic hepatitis is unclear. In a retrospective multicenter study, we have analyzed the virological events observed during lamivudine therapy in patients with HBeAgnegative chronic hepatitis an